Elicio Therapeutics Inc
Change company Symbol lookup
Select an option...
ELTX Elicio Therapeutics Inc
HOLX Hologic Inc
FEMY Femasys Inc
HT Hersha Hospitality Trust
SABS SAB Biotherapeutics Inc
DIA SPDR® Dow Jones Industrial Average ETF Trust
SPY SPDR® S&P 500 ETF Trust
ABBNY Abb Ltd
FCF First Commonwealth Financial Corp
ARMN Aris Mining Corp
Go

Health Care : Biotechnology |
Company profile

Elicio Therapeutics, Inc., formerly Angion Biomedica Corp., is a clinical-stage biotechnology company. The Company is engaged in developing a pipeline of immunotherapies for the treatment of cancer and other diseases. It provides a platform, amphiphile (AMP) that delivers immuno therapeutics directly to the lymph nodes (brain center) of the immune system. The Company's lead product candidate, ELI-002, is being developed to treat cancers driven by kirsten rat sarcoma (KRAS). It is conducting a Phase I/II clinical trial of ELI-002 (AMPLIFY-201). The Company is also evaluating the use of ELI-004, a universal AMP-modified clinical practice guidelines (CpG) adjuvant to treat or prevent additional diseases. The Company provides anaplastic lymphoma kinase (ALK) program to identify an internal development candidate. The Company conducts assessments for using ELI-004 to induce immune responses targeting severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

Closing Price
$7.98
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
31

10-day average volume:
25,373
31
  • Prev Close
    7.98
  • Today's Open
    --
  • Day's Range
    --
  • Avg Vol (10-day)
    25.4K
  • Last (time)
    4:00p ET 10/02/23
  • Last (size)
    1
  • 52-Wk Range
    4.60 - 24.39
    LowHigh
  • (03/21/23 - 06/02/23)
    73.48%
  • 108.9%
  • Market Cap
    66.9M
  • Shares Outstanding
    8.4M
  • -10.89
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • --
  • 5.79
  • (% of float 09/15/23)
    0.92

Earnings Calendar and Events Data provided by |Terms of Use| © 2023 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2023. All rights reserved.